These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15647416)

  • 1. Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine.
    Dowell JA; Stogniew M; Krause D; Henkel T; Weston IE
    J Clin Pharmacol; 2005 Feb; 45(2):227-33. PubMed ID: 15647416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
    Dowell JA; Schranz J; Baruch A; Foster G
    J Clin Pharmacol; 2005 Dec; 45(12):1373-82. PubMed ID: 16291712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers.
    Hebert MF; Townsend RW; Austin S; Balan G; Blough DK; Buell D; Keirns J; Bekersky I
    J Clin Pharmacol; 2005 Aug; 45(8):954-60. PubMed ID: 16027407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anidulafungin: a new echinocandin with a novel profile.
    Vazquez JA
    Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal.
    Dowell JA; Knebel W; Ludden T; Stogniew M; Krause D; Henkel T
    J Clin Pharmacol; 2004 Jun; 44(6):590-8. PubMed ID: 15145966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.
    Dowell JA; Stogniew M; Krause D; Henkel T; Damle B
    J Clin Pharmacol; 2007 Mar; 47(3):305-14. PubMed ID: 17322142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anidulafungin: a novel echinocandin.
    Vazquez JA; Sobel JD
    Clin Infect Dis; 2006 Jul; 43(2):215-22. PubMed ID: 16779750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
    Groll AH; Mickiene D; Petraitiene R; Petraitis V; Lyman CA; Bacher JS; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2845-55. PubMed ID: 11557479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.
    Wagner C; Graninger W; Presterl E; Joukhadar C
    Pharmacology; 2006; 78(4):161-77. PubMed ID: 17047411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment.
    Dowell JA; Stogniew M; Krause D; Damle B
    J Clin Pharmacol; 2007 Apr; 47(4):461-70. PubMed ID: 17389555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
    Krause DS; Simjee AE; van Rensburg C; Viljoen J; Walsh TJ; Goldstein BP; Wible M; Henkel T
    Clin Infect Dis; 2004 Sep; 39(6):770-5. PubMed ID: 15472806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
    Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
    Romero AJ; Le Pogamp P; Nilsson LG; Wood N
    Clin Pharmacol Ther; 2002 Apr; 71(4):226-34. PubMed ID: 11956505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
    Simonson SG; Raza A; Martin PD; Mitchell PD; Jarcho JA; Brown CD; Windass AS; Schneck DW
    Clin Pharmacol Ther; 2004 Aug; 76(2):167-77. PubMed ID: 15289793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
    Cross DM; Chmielewski G; Lewis EM; Liu L; Modesitt MS; Ripp SL; Sawaryn CM; Bowman CJ
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):29-39. PubMed ID: 22343256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.
    Heresi GP; Gerstmann DR; Reed MD; van den Anker JN; Blumer JL; Kovanda L; Keirns JJ; Buell DN; Kearns GL
    Pediatr Infect Dis J; 2006 Dec; 25(12):1110-5. PubMed ID: 17133155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.